Blueteq News
CYPRUS – GeSY — System Overview and Access Data
Cyprus’s national health system GeSY (General Healthcare System) marked its seventh anniversary in September 2026, with the Health Insurance Organisation (HIO) reporting 1,036,681 registered beneficiaries
RTÉ Investigates — Opioid prescribing under public drug schemes
An RTÉ Investigates analysis published on 28 September 2026 found that opioid prescribing under Ireland’s General Medical Services (GMS) scheme rose approximately 12% per eligible
AWMSG Annual Report 2025–26
The All Wales Medicines Strategy Group published its Annual Report for 2025–26 on 7 September 2026.1 The report records that 76 medicines were subject to
SMC Decisions — 7 September 2026
The Scottish Medicines Consortium published advice on eight medicines on 7 September 2026. All eight were accepted:1 Eight high-cost specialist medicines accepted in a single
NICE Technology Appraisals
NICE published final draft guidance on 3 September 2026 recommending mirdametinib (Ezmekly®) for the treatment of neurofibromatosis type 1 (NF1)-associated plexiform neurofibromas in children and
HSE Approves Skyclarys (Omaveloxolone) for Friedreich’s Ataxia
On 25 August 2026 the HSE Senior Management Team approved the reimbursement of omaveloxolone (Skyclarys®, Biogen) for patients with Friedreich’s Ataxia, a rare progressive neurological
